Key facts
- Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators.
- MedaSync’s last known valuation is $11.2M (Aug 2025).
- It has raised $3.6M across 2 recorded rounds; the latest was Seed Round ($1.6M) in Feb 2024.
- Notable investors include Interstate Fusion Ventures, Aztec Capital, Innovation Fund America, Omega Healthcare Investors, Valley Growth Ventures — 6 tracked in total.
- MedaSync has filed 2 Form Ds with the SEC since 2018, most recently Aug 2025 ($1.6M sold to 18 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for MedaSync
Create free account
No card required
Funding rounds
2 roundsAbout MedaSync
Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators. The company's software helps in revenue optimization, controlling costs and evaluating historical and real-time data to identify trends and support decision-making, enabling healthcare businesses to provide quality care while maintaining profitability.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2016
- Employees
- 7
- Website
- medasync.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
MedaSync doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.